HQY · Insider Trading

HealthEquity, Inc

Every open-market purchase and sale reported by HQY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
4
code S
Reporting Insiders
18
current holders
HQY — Recent Form 4 Transactions (latest 2026-10-19)
FiledInsiderRole TypeSharesValue
2026-10-19 Sunil Rajasekar EVP Chief Prod & Strat Officer MIXED — −$1.37K
2026-10-08 Michael Henry Fiore — F −2,032 −$185.23K
2026-10-08 Delano Ladd EVP, General Counsel F −1,080 −$98.45K
2026-10-08 James M Lucania EVP & CFO F −2,822 −$257.24K
2026-10-08 Stephen Neeleman FOUNDER AND VICE CHAIRMAN F −1,095 −$99.82K
2026-10-08 Michael Gathright Chief Customer Officer F −662 −$60.34K
2026-10-08 Scott Cutler President and CEO F −1,230 −$112.12K
2026-09-18 Stephen Neeleman FOUNDER AND VICE CHAIRMAN G −1,500 —
2026-08-27 Adrian T Dillon Director MIXED — −$550.33K
2026-07-14 Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER Sell −2,354 −$223.63K
2026-07-13 Michael Gathright Chief Customer Officer F −2,270 −$211.26K
2026-07-10 Delano Ladd EVP, General Counsel F −1,087 −$103.36K
2026-07-10 James M Lucania EVP & CFO F −2,839 −$269.94K
2026-07-10 Scott Cutler President and CEO F −1,238 −$117.71K
2026-07-10 Stephen Neeleman FOUNDER AND VICE CHAIRMAN F −1,103 −$104.88K
2026-07-10 Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER F −2,045 −$194.44K
2026-07-07 Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER Sell −2,470 −$234.65K
2026-06-29 Robert W Selander Director A +2,877 —
2026-06-29 Debra Charlotte McCowan Director A +2,877 —
2026-06-29 Stuart B. Parker Director A +2,877 —
2026-06-29 Rajesh Natarajan Director A +2,877 —
2026-06-29 Gayle Furgurson Wellborn Director A +2,877 —
2026-06-29 Evelyn S Dilsaver Director A +2,877 —
2026-06-29 Adrian T Dillon Director A +2,877 —
2026-06-29 William Gassen Director A +2,877 —
2026-06-02 Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER Sell −3,142 −$298.49K
2026-06-01 Delano Ladd EVP, General Counsel Sell −7,500 −$675.00K
2026-06-01 Gayle Furgurson Wellborn Director MIXED — −$104.36K
2026-04-08 Scott Cutler President and CEO F −4,931 −$413.40K
2026-04-08 James M Lucania EVP & CFO F −4,393 −$368.29K
2026-04-08 Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER F −4,768 −$399.73K
2026-04-08 Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER F −3,378 −$283.20K
2026-04-08 Delano Ladd EVP, General Counsel F −2,481 −$208.00K
2026-04-08 Stephen Neeleman FOUNDER AND VICE CHAIRMAN F −2,559 −$214.54K
2026-04-02 Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER F −18,010 −$1.49M
2026-04-02 Stephen Neeleman FOUNDER AND VICE CHAIRMAN F −9,292 −$766.84K
2026-04-02 Delano Ladd EVP, General Counsel F −7,726 −$637.60K
2026-03-27 Scott Cutler President and CEO A +72,754 —
2026-03-27 James M Lucania EVP & CFO A +27,283 —
2026-03-27 Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER A +60,607 —
2026-03-27 Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER A +17,582 —
2026-03-27 Stephen Neeleman FOUNDER AND VICE CHAIRMAN A +39,775 —
2026-03-27 Michael Gathright Chief Customer Officer A +15,157 —
2026-03-27 Delano Ladd EVP, General Counsel A +35,608 —
2026-02-04 Rajesh Natarajan Director A +976 —
2026-02-04 Stuart B. Parker Director A +1,263 —
2026-01-14 Scott Cutler President and CEO F −12,496 −$1.12M
2026-01-13 Delano Ladd EVP, General Counsel F −739 −$70.38K
2026-01-13 Stephen Neeleman FOUNDER AND VICE CHAIRMAN F −791 −$75.33K
2026-01-13 Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER F −2,074 −$197.52K
HQY — Current Insider Holders
InsiderRole Shares HeldValue
Jon Kessler PRESIDENT AND CEO 392,700 $39.65M
Stephen Neeleman FOUNDER AND VICE CHAIRMAN 339,470 $34.28M
Scott Cutler President and CEO 175,175 $17.69M
James M Lucania EVP & CFO 101,795 $10.28M
Robert W Selander Director 89,849 $9.07M
Delano Ladd EVP, General Counsel 88,974 $8.98M
Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER 81,497 $8.23M
Adrian T Dillon Director 63,727 $6.43M
Sunil Rajasekar EVP Chief Prod & Strat Officer 53,405 $5.39M
Evelyn S Dilsaver Director 51,085 $5.16M
Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER 50,212 $5.07M
Michael Gathright Chief Customer Officer 39,231 $3.96M
Stuart B. Parker Director 25,975 $2.62M
Gayle Furgurson Wellborn Director 22,610 $2.28M
Rajesh Natarajan Director 18,130 $1.83M
Debra Charlotte McCowan Director 12,659 $1.28M
Frank Corvino Director 3,784 $382.07K
William Gassen Director 3,611 $364.60K
HQY Insider Trading FAQ
Who are the insiders at HQY?
18 officers, directors and 10%+ beneficial owners currently report holdings in HQY via SEC Form 4.
Are HQY insiders buying or selling?
Across the 50 most recent Form 4 filings for HQY, 0 were open-market purchases (code P) and 4 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is HQY insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent HQY filing is dated 2026-10-19.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the HQY quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.